Europe Human Leukocyte Antigen (HLA) Testing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Human Leukocyte Antigen (HLA) Testing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Human Leukocyte Antigen (HLA) Testing Market Regional Analysis

6.2 Europe Human Leukocyte Antigen (HLA) Testing Market Revenue 2020-2028 (US$ Million)

6.3 Europe Human Leukocyte Antigen (HLA) Testing Market Forecast Analysis

7. Europe Human Leukocyte Antigen (HLA) Testing Market Analysis – by Product and service

7.1 Reagents & Consumables

7.1.1 Overview
7.1.2 Reagents & Consumables: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Software & Services

7.3.1 Overview
7.3.2 Software & Services: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Human Leukocyte Antigen (HLA) Testing Market Analysis – by Technology

8.1 Molecular Assay Technologies

8.1.1 Overview
8.1.2 Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Non-Molecular Assay Technologies

8.2.1 Overview
8.2.2 Non-Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Human Leukocyte Antigen (HLA) Testing Market Analysis – by End User

9.1 Independent Reference Laboratories

9.1.1 Overview
9.1.2 Independent Reference Laboratories: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Hospitals and Transplant Centers

9.2.1 Overview
9.2.2 Hospitals and Transplant Centers: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Human Leukocyte Antigen (HLA) Testing Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.2.1.1.2 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.2.1.1.3 UK: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

10.2.1.2 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.2.1.2.2 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.2.1.2.3 Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

10.2.1.3 France: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.2.1.3.2 France: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.2.1.3.3 France: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

10.2.1.4 Russia: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.2.1.4.2 Russia: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.2.1.4.3 Russia: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

10.2.1.5 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.2.1.5.2 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.2.1.5.3 Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Product and service
10.2.1.6.2 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by Technology
10.2.1.6.3 Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 CareDx

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Illumina, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Bio-Rad Laboratories, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 F. HOFFMANN-LA ROCHE LTD.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Takara Bio Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Luminex Corporation

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Omixon Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Protrans

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 CeGaT GmbH

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Human Leukocyte Antigen (HLA) Testing Market

Analysis By Product and service (Reagents & Consumables, Instruments, and Software & Services), Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others)